棕榈酸帕利哌酮与利培酮治疗首次发病精神分裂症患者的长期疗效和安全性对比分析OA
Long-term Efficacy and Safety of Palmitic Acid Paliperidone and Risperidone in the Treatment of First-onset Schizoiphrenia
目的:探讨棕榈酸帕利哌酮与利培酮对于首次发病的精神分裂症患者长期疗效及用药安全性差异.方法:将2013年9月—2014年3月就诊于本院的首次发病精神分裂症患者80例,按照随机数字表法将患者分为两组,分别应用棕榈酸帕利哌酮(帕利哌酮组)及利培酮(利培酮组)进行药物治疗,对比两种药物治疗24个月后患者的治疗效果及不良反应发生情况.结果:于12个月、18个月比较,帕利哌酮组患者阳性与阴性症状量表(PANSS)评分显著低于利培酮组患者(t =-4.081…查看全部>>
Objective:To investigate the long-term efficacy and safety of risperidone palmitate and risperidone in patients with first-onset schizophrenia.Methods:Eighty patients with schizophrenia were enrolled in our hospital from September 2013 to March 2014,the patients were divided into two groups according to the random number table method.The patients were treated with palmitic acid paliperidone(parylidone group)and risperidone(risperidone group).Compared with th…查看全部>>
张大春
中国.湖北省宜昌市精神卫生中心 443000
医药卫生
帕利哌酮利培酮精神分裂症阳性与阴性症状量表
PaliperidoneRisperidoneSchizophreniaPANSS
《中国健康心理学杂志》 2017 (11)
1611-1614,4
评论